SC 13G

Company

Biodexa Pharmaceuticals Plc

Filed

November 4, 2019

Accession Number

0000919574-19-006693

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →